Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway
The aim of this study was to establish whether a universal pneumococcal vaccination for older adults in Norway is likely to be cost-effective from the perspective of the health care provider. A decision tree model developed by the Public Health Agency of Sweden was adopted to the Norwegian setting....
| Κύριοι συγγραφείς: | , , , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Taylor & Francis Group
2022-11-01
|
| Σειρά: | Human Vaccines & Immunotherapeutics |
| Θέματα: | |
| Διαθέσιμο Online: | http://dx.doi.org/10.1080/21645515.2022.2101333 |